Tenon Medical appoints Kristine Jacques to Board of Directors effective March 25, 2024

Tenon Medical, Inc.

Ms. Jacques brings over 35 years of medtech experience, most recently VP & GM at Vivex Biologics.
Board expands to seven members, including four independent directors.
Her expertise in spinal-device commercialization is expected to aid Tenon's Catamaran System strategy.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kristine Jacques

Director

TNON · Tenon Medical, Inc.

Effective: 2024-03-25
Filed: April 1, 2024, 7:59 PM ET

On March 25, 2024, the Board of Directors (the “Board”) of Tenon Medical, Inc. (the “Company”) appointed Kristine Jacques as a member of the Board effective as of March 25, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kristine Jacques was appointed as Director at Tenon Medical, Inc..

Action: appointed
Role: Director

Exact text from the filing

On March 25, 2024, the Board of Directors (the “Board”) of Tenon Medical, Inc. (the “Company”) appointed Kristine Jacques as a member of the Board effective as of March 25, 2024.

View on SEC.gov

Tenon Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-028169

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.